MediWound (MDWD) Research & Development (2013 - 2025)

MediWound's Research & Development history runs 13 years deep, the most recent figure standing at $4.5 million for Q4 2025.

• On a quarterly basis, Research & Development rose 49.97% year-over-year to $4.5 million in Q4 2025; TTM through Dec 2025 was $14.3 million, a 61.3% increase from a year earlier, with the FY2025 full-year figure at $14.3 million, up 61.3% from the prior year.
• Research & Development grew to $4.5 million in Q4 2025 per MDWD's latest filing, from $3.5 million in the prior quarter.
• Across five years, Research & Development topped out at $4.5 million in Q4 2025 and bottomed at $1.5 million in Q1 2024.
• The 5-year median for Research & Development is $2.5 million (2021), against an average of $2.6 million.
• Across the five-year window, Research & Development slumped 46.83% in 2023 and surged 96.33% in 2025, its largest moves.
• Year by year, Research & Development stood at $2.5 million in 2021, then grew by 9.67% to $2.7 million in 2022, then sank by 33.01% to $1.8 million in 2023, then soared by 65.15% to $3.0 million in 2024, then jumped by 49.97% to $4.5 million in 2025.
• Per Business Quant, the three latest MDWD Research & Development figures stand at $4.5 million (Q4 2025), $3.5 million (Q3 2025), and $3.5 million (Q2 2025).